BioAdaptives, Inc.
BDPT
$0.0005
$0.000.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.20K | 15.60K | 2.30K | 3.40K | 4.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.20K | 15.60K | 2.30K | 3.40K | 4.00K |
| Cost of Revenue | 4.50K | 11.00K | 800.00 | 1.40K | 3.00K |
| Gross Profit | 2.70K | 4.70K | 1.50K | 2.00K | 1.00K |
| SG&A Expenses | 75.30K | 59.20K | 56.80K | 20.30K | 27.60K |
| Depreciation & Amortization | -10.80K | 37.60K | 700.00 | 700.00 | 700.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.00K | 107.90K | 58.30K | 22.40K | 31.30K |
| Operating Income | -61.80K | -92.20K | -55.90K | -19.00K | -27.30K |
| Income Before Tax | -268.30K | -13.10K | -143.90K | -287.20K | -28.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -268.30K | -13.10K | -143.90K | -287.20K | -28.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -268.30K | -13.10K | -143.90K | -287.20K | -28.30K |
| EBIT | -61.80K | -92.20K | -55.90K | -19.00K | -27.30K |
| EBITDA | -54.70K | -54.60K | -55.30K | -18.30K | -26.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 787.88M | 730.01M | 441.74M | 267.43M | 191.20M |
| Average Diluted Shares Outstanding | 787.88M | 730.01M | 441.74M | 267.43M | 191.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
